[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Otto Bock France SNC\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":75},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100612385","exopulse-suit-and-walking-ability-of-patients-with-multiple-sclerosis-100612385",false,"NCT07252895","EXOPULSE Suit and Walking Ability of Patients With Multiple Sclerosis","Walking Ability of Patients With Multiple Sclerosis Using the EXOPULSE Suit: Randomized Controlled Crossover Trial","EXO-MOBILITY","Inclusion Criteria:\n\n* Person with a clear Multiple Sclerosis diagnosis according to the 2017 revision of the McDonald criteria since at least 3 months.\n* Person with an Expanded Disability Status Scale (EDSS) score ≥ 4 and ≤ 6\n* Person with stable walking ability for at least two weeks prior to the inclusion visit (variation at the MSWS-12 questionnaire \\\u003C 8\u002F100 points)\n* Person not treated with fampridine due to contra-indication or adverse events or not respondent or no longer respondent or reluctant to taking drugs\n* Person with spasticity at the lower limb(s), attested by a Modified Ashworth Scale ≥ 1+ of at least one of the following muscle groups: quadriceps, hamstrings, triceps surae, tibialis anterior\n* Person who never tried EXOPULSE SUIT\n\nExclusion Criteria:\n\n* Person under 18 years old\n* Person having a contraindication to using EXOPULSE SUIT\n* Person using an electronic life-support equipment, e.g. pacemakers or hight-frequency surgical equipment and person using an ECG equipment\n* Person affected by other somatic or neuropsychiatric diagnoses (e.g., arrhythmias, uncontrolled epilepsy, diseases causing osteoarticular and muscular pain).\n* Person with relapses over the last 3 months before the inclusion\n* Person who had a modification of his\u002Fher medical treatments of the multiple sclerosis or related to motor performance over the last 3 months before the inclusion\n* Person who had a new medical treatment of the multiple sclerosis or related to motor performance over the last 3 months before the inclusion\n* Person who had an injection of botulinum toxin in at least one of the main muscle groups of the lower limbs over the last 4 months before the inclusion\n* Person planning to use a new medical device during the study (ex: ankle-foot orthosis…)\n* Person undergoing or planning to undergo an intensive rehabilitation phase\n* Person that is part of another study\n* Person who cannot be fitted with EXOPULSE SUIT due to inexistent Suitable size of the Suit (eg: BMI\\>35; user height \\\u003C 100 cm or \\> 205cm)\n* Person who does not have a smartphone or who cannot or does not want to use his\u002Fher smartphone for operating the EXOPULSE App\n* Person not available to undergo all medical visits during the study\n* Person unable to understand verbal and written instructions in french\n* Pregnant person\n* Persons under juridical protection\n* Prisoners","ALL","18 Years",{"count":20,"type":21},77,"ESTIMATED","INTERVENTIONAL",[24],"NA","The EXOPULSE Suit is a medical device composed of 50 electrodes capable of stimulating up to 43 major muscle groups throughout the body. The multisite electrical stimulation relaxes tense and spastic muscles, thereby enhancing mobility and balance. This non-invasive body garment is intended for home use and should be used for 1 hour every other day.\n\nThis research aims to confirm the benefits of the EXOPULSE Suit in individuals with Multiple Sclerosis, including improvements in walking ability.",[27],"Multiple Sclerosis",[27,29,30,31,32],"neuromodulation","suit","walking ability","multi-site electrical stimulation","RECRUITING","2026-03-31",{"date":36,"type":37},"2026-04-06","ACTUAL",{"date":39,"type":37},"2026-03-30",{"date":41,"type":21},"2027-03",{"name":43,"class":44},"Otto Bock France SNC","INDUSTRY",11,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":22,"phases":56,"briefSummary":57,"conditions":58,"keywords":61,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},"100609431","study-on-a-prosthetic-foot-with-adjustable-heel-height-100609431","NCT07214493","Study on a Prosthetic Foot With Adjustable Heel Height","Impact of a Prosthetic Foot With Adjustable Heel Height on Physical Appearance and Participation: a Randomized Crossover Trial.","ADJUST","Inclusion Criteria :\n\n* Adult patient with a major lower limb amputation whose life project includes:\n* movement in buildings other than the home (ICF d4601),\n* movement outside the home and other buildings (ICF d4602),\n* and other specified activities related to movement in other various places (ICF d4608).\n* Patient who has been using an Enregy storage and Return (ESR) foot for at least 3 months\n* Patient who wishes to walk with shoes with different heel heights, and\u002For barefoot\n\nExclusion Criteria:\n\n* Patient with a high impact level (e.g.: sport)\n* Patient with hip disarticulation or equivalent\n* Patient with an unstabilised residual limb and\u002For an unsuitable socket\n* Patient who cannot be fitted with a Taleo Adjust foot due to the technical characteristics of the product (user weight greater than 115kg; required foot size \\\u003C22 or \\>28; mounting height less than 118 mm)\n* Patient whose usual foot has a heel height adjustment system\n* Patient unavailable for the duration of the study and\u002For unable to understand the instructions and\u002For answer questionnaires in French\n* Patient already participating in another study\n* Patient in an emergency situation or pregnant woman",{"count":55,"type":21},30,[24],"Most prosthetic feet have a fixed heel height, which requires users to always wear shoes with the same heel height. A fixed heel height is a significant constraint, whereas the ability to choose one's clothing freely is an important aspect of coping with a physical disability.\n\nThe Taleo Adjust is a prosthetic foot with a hydraulic ankle that allows the user to adjust the heel height from 0 to 7 cm, depending on the type of shoe worn.\n\nThis study aims to evaluate the impact of an adjustable-heel-height foot on physical appearance and participation.",[59,60],"Lower Limb Amputation Above Knee","Lower Limb Amputation Below Knee",[62,63,64,65],"Lower limb amputation","Prosthetic foot","Adjustable heel height","Hydraulic ankle","2025-11-20",{"date":68,"type":37},"2025-11-25",{"date":70,"type":37},"2025-10-08",{"date":72,"type":21},"2026-06-06",{"name":43,"class":44},5,""]